1.Constructing a Predictive Model for Gastric Cancer Immunotherapy Response Based on Transcriptomic Gene Expression Profiles
Tianyu HAO ; Baolin HAN ; Wei JIANG ; Xiangshang XU ; Jianhong WU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2026;55(2):155-163
Objective To identify core genes influencing immunotherapy response in gastric cancer and to establish a corresponding predictive model. Methods Gene expression data from gastric cancer patients treated with immunotherapy were obtained from the GEO and the TIDE databases.Differentially expressed genes were screened,and weighted gene co-expression network analysis(WGCNA)was performed,identifying 185 genes associated with immunotherapy response for gastric cancer.Core genes were further selected via three machine-learning algorithms:Least Absolute Shrinkage and Selection Operator(LASSO),Random Forest(RF),and Support Vector Machine-Recursive Feature Elimination(SVM-RFE).A predictive model was constructed based on these core genes and validated externally.Model performance was assessed using ROC curves.Additional validation was carried out on an independent dataset GSE62254.Single-cell RNA sequencing was employed to examine the expression of core genes across cell subpopulations. Results A predictive model comprising five core genes was developed,which stratified a cohort of 300 gastric cancer patients into high- and low-risk subgroups.The high-risk group exhibited higher tumor-microenvironment infiltration,TIDE scores,T-cell dysfunction,cancer-associated fibroblast activity,and expression of specific immune-checkpoint molecules,together with lower microsatellite instability scores,collectively indicating enhanced immune escape potential and poorer response to immune checkpoint inhibitors.Single-cell analysis confirmed heterogeneous expression patterns of the five core genes among different cell types. Conclusion A robust predictive model based on differentially expressed core genes related to gastric cancer immunotherapy response was constructed.This model may offer potential value for future research and could aid in clinical decision-making.
2.Role of RANTES and its receptor in gastric cancer metastasis.
Zhixin, CAO ; Xiangshang, XU ; Xuelai, LUO ; Li, LI ; Bin, HUANG ; Xiaolan, LI ; Deding, TAO ; Junbo, HU ; Jianping, GONG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2011;31(3):342-7
This study examined the role of regulated upon activation normal T cell expressed and secreted (RANTES) and its receptor C-C chemokine receptor type 5 (CCR5) in gastric cancer metastasis and the associated mechanism. The expression of RANTES and CCR5 was detected by using immunohistochemical staining and Western blotting in the gastric cancer tissues obtained from 60 gastric cancer patients with or without lymph node metastasis (n=30 in each). The results showed that the expression levels of RANTES and CCR5 were higher in gastric cancer with lymph node metastasis than in that without metastasis (P<0.05). The expression levels of RANTES in 30 lymph nodes with cancerous invasion were higher than in 30 normal lymph nodes (P<0.05). Chemotactic test revealed that the number of migrating gastric cancer cells (n=295.0±54.6) induced by the protein of cancer-invading lymph nodes was greater than that by the protein mixture from cancer-invading lymph nodes and RANTES antibody (n=42.5±11.6) (P<0.05). RT-PCR showed that the expression levels of the main Th1 cytokines (IL-2, Γ-IFN) were lower in gastric cancer with lymph node metastasis (2.22±0.90, 3.26±1.15 respectively) than in that without metastasis (3.07±1.67, 4.77±1.52 respectively) (P<0.05), but the expression level of the main Th 2 cytokine (IL-10) was higher in gastric cancer with lymph nodes metastasis (6.06±2.04) than in that without metastasis (4.88±1.87) (P<0.05). It was concluded that RANTES and its receptor CCR5 may contribute to gastric cancer metastasis through influencing the balance of Th1/Th2. RANTES and CCR5 may become a marker of gastric cancer metastasis.
3.Role of RANTES and Its Receptor in Gastric Cancer Metastasis
CAO ZHIXIN ; XU XIANGSHANG ; LUO XUELAI ; LI LI ; HUANG BIN ; LI XIAOLAN ; TAO DEDING ; HU JUNBO ; GONG JIANPING
Journal of Huazhong University of Science and Technology (Medical Sciences) 2011;31(3):342-347
This study examined the role of regulated upon activation normal T cell expressed and secreted (RANTES) and its receptor C-C chemokine receptor type 5 (CCR5) in gastric cancer metastasis and the associated mechanism.The expression of RANTES and CCR5 was detected by using immunohistochemical staining and Western blotting in the gastric cancer tissues obtained from 60 gastric cancer patients with or without lymph node metastasis (n=30 in each).The results showed that the expression levels of RANTES and CCR5 were higher in gastric cancer with lymph node metastasis than in that without metastasis (P<0.05).The expression levels of RANTES in 30 lymph nodes with cancerous invasion were higher than in 30 normal lymph nodes (P<0.05).Chemotactic test revealed that the number of migrating gastric cancer cells (n=295.0±54.6) induced by the protein of cancer-invading lymph nodes was greater than that by the protein mixture from cancer-invading lymph nodes and RANTES antibody (n=42.5+11.6) (P<0.05).RT-PCR showed that the expression levels of the main Th1 cytokines (IL-2,γ-IFN) were lower in gastric cancer with lymph node metastasis (2.22±0.90,3.26±1.15 respectively)than in that without metastasis (3.07±1.67,4.77±1.52 respectively) (P<0.05),but the expression level of the main Th 2 cytokine (IL-10) was higher in gastric cancer with lymph nodes metastasis (6.06±2.04)than in that without metastasis (4.88±1.87) (P<0.05).It was concluded that RANTES and its receptor CCR5 may contribute to gastric cancer metastasis through influencing the balance of Th1/Th2.RANTES and CCR5 may become a marker of gastric cancer metastasis.
4.MULTI-FUNCTION ADJUSTABLE MODULATABLE ANESTHETIC LARYNGOSCOPE
Chinese Medical Equipment Journal 1989;0(04):-
This paper introduces a multi-function adjustable anesthetic laryngoscope.The laryngocope or called tongue-spatula can be adjusted freely in length between12-14cm and in ante-posterior diameter between 2.8-4.5cm according to patients'condition.An oxygen -supply pipe and suction tube are settled on the bottom and side of tongue-spatula to provide oxygen and absorb phlegm simultaneously on exposure of glottis.The tongue-spatula not only fits for normal adults but also for those with high prominewtia,short neck,long epiglottis, absent of incisor teeth as well as tall and fatty persons.It has got satisfying result in 29 cases of medical experiment.


Result Analysis
Print
Save
E-mail